Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults
Open Access
- 9 December 2021
- Vol. 25 (1) , 103595
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- Fundación Banco Santander
- Departament de Salut, Generalitat de Catalunya (SLT006/17/00199)
- Banco Santander
- Generalitat de Catalunya
- Stavros Niarchos Foundation
- Instituto de Salud Carlos III
This publication has 34 references indexed in Scilit:
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19Science Immunology, 2020
- Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19Cell Host & Microbe, 2020
- A Dynamic Immune Response Shapes COVID-19 ProgressionCell Host & Microbe, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- SARS-CoV-2: a storm is ragingJournal of Clinical Investigation, 2020
- COVID-19 in Children: Clinical Approach and ManagementIndian Journal of Pediatrics, 2020
- Clinical and immunological features of severe and moderate coronavirus disease 2019Journal of Clinical Investigation, 2020
- Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adultsActa Paediatrica, 2020
- Development of a Validated Interferon Score Using NanoString TechnologyJournal of Interferon & Cytokine Research, 2018
- Regulation of type I interferon responsesNature Reviews Immunology, 2013